For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Astera Labs Inc (NASDAQ: ALAB) closed at $161.01 down -3.65% from its previous closing price of $167.11. In other words, the price has decreased by -$3.65 from its previous closing price. On the day, 8.02 million shares were traded. ALAB stock price reached its highest trading level at $166.89 during the session, while it also had its lowest trading level at $151.1.
Ratios:
For a deeper understanding of Astera Labs Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 118.53. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 20, 2025, BNP Paribas Exane started tracking the stock assigning a Outperform rating and target price of $225.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 02 ’26 when Mazzara Philip sold 10,000 shares for $178.41 per share. The transaction valued at 1,784,071 led to the insider holds 137,040 shares of the business.
PHILIP MAZZARA bought 30,000 shares of ALAB for $4,990,800 on Jan 02 ’26. On Dec 01 ’25, another insider, ALBA MANUEL, who serves as the Director of the company, sold 33,000 shares for $166.18 each. As a result, the insider received 5,483,981 and left with 352,863 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 27195170816 and an Enterprise Value of 26092064768. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 143.35, and their Forward P/E ratio for the next fiscal year is 66.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 37.61 while its Price-to-Book (P/B) ratio in mrq is 21.38. Its current Enterprise Value per Revenue stands at 36.087 whereas that against EBITDA is 233.871.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.53, which has changed by 0.27789247 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is 0.04%, while the 200-Day Moving Average is calculated to be 18.81%.
Shares Statistics:
For the past three months, ALAB has traded an average of 5.92M shares per day and 4034500 over the past ten days. A total of 168.90M shares are outstanding, with a floating share count of 134.35M. Insiders hold about 20.46% of the company’s shares, while institutions hold 66.28% stake in the company. Shares short for ALAB as of 1765756800 were 12293014 with a Short Ratio of 2.08, compared to 1763078400 on 10645508. Therefore, it implies a Short% of Shares Outstanding of 12293014 and a Short% of Float of 9.8400004.
Earnings Estimates
Investors are keenly observing as 19.0 analysts analyze and rate. The current performance of Astera Labs Inc (ALAB) in the stock market.The consensus estimate for the next quarter is $0.52, with high estimates of $0.56 and low estimates of $0.47.
Analysts are recommending an EPS of between $1.8 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.37, with 19.0 analysts recommending between $2.81 and $2.0.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $249.46M this quarter.It ranges from a high estimate of $251.3M to a low estimate of $248.9M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 17 analysts are estimating revenue of $258.71M. There is a high estimate of $266.45M for the next quarter, whereas the lowest estimate is $249.1M.
A total of 21 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $833.3M, while the lowest revenue estimate was $774.54M, resulting in an average revenue estimate of $827.5M. In the same quarter a year ago, actual revenue was $396.29MBased on 19 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.07B.
